146 related articles for article (PubMed ID: 34226091)
1. Tobacco Treatment Specialist Training for Lung Cancer Screening Providers.
Roughgarden KL; Toll BA; Tanner NT; Frazier CC; Silvestri GA; Rojewski AM
Am J Prev Med; 2021 Nov; 61(5):765-768. PubMed ID: 34226091
[No Abstract] [Full Text] [Related]
2. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.
Rojewski AM; Tanner NT; Dai L; Ravenel JG; Gebregziabher M; Silvestri GA; Toll BA
Chest; 2018 Jul; 154(1):110-118. PubMed ID: 29793736
[TBL] [Abstract][Full Text] [Related]
3. Integrating smoking cessation into lung cancer screening programs.
Pua BB; Dou E; O'Connor K; Crawford CB
Clin Imaging; 2016; 40(2):302-6. PubMed ID: 26088006
[TBL] [Abstract][Full Text] [Related]
4. Receipt of Tobacco Treatment and One-Year Smoking Cessation Rates Following Lung Cancer Screening in the Veterans Health Administration.
Heffner JL; Coggeshall S; Wheat CL; Krebs P; Feemster LC; Klein DE; Nici L; Johnson H; Zeliadt SB
J Gen Intern Med; 2022 May; 37(7):1704-1712. PubMed ID: 34282533
[TBL] [Abstract][Full Text] [Related]
5. Lung Cancer Screening, Cancer Treatment, and Addressing the Continuum of Health Risks Caused by Tobacco.
Warren GW; Ostroff JS; Goffin JR
Am Soc Clin Oncol Educ Book; 2016; 35():223-9. PubMed ID: 27249702
[TBL] [Abstract][Full Text] [Related]
6. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A
Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378
[TBL] [Abstract][Full Text] [Related]
7. Readiness of Lung Cancer Screening Sites to Deliver Smoking Cessation Treatment: Current Practices, Organizational Priority, and Perceived Barriers.
Ostroff JS; Copeland A; Borderud SP; Li Y; Shelley DR; Henschke CI
Nicotine Tob Res; 2016 May; 18(5):1067-75. PubMed ID: 26346948
[TBL] [Abstract][Full Text] [Related]
8. Lung Cancer Screening Eligibility, Risk Perceptions, and Clinician Delivery of Tobacco Cessation Among Patients With Schizophrenia.
Irwin KE; Steffens EB; Yoon Y; Flores EJ; Knight HP; Pirl WF; Freudenreich O; Henderson DC; Park ER
Psychiatr Serv; 2019 Oct; 70(10):927-934. PubMed ID: 31357921
[TBL] [Abstract][Full Text] [Related]
9. Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program.
Raz DJ; Wu G; Nelson RA; Sun V; Wu S; Alem A; Haupt EC; Ismail MH; Gould MK
Clin Lung Cancer; 2019 Jan; 20(1):e115-e122. PubMed ID: 30585165
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer screening-Marching along ….
Fong KM; Marshall HM; Lam DCL
Respirology; 2022 Aug; 27(8):578-580. PubMed ID: 35581523
[No Abstract] [Full Text] [Related]
11. Smoking Cessation Resources Can and Should Be Integrated in Lung Cancer Screening.
Zeliadt SB
Chest; 2021 Aug; 160(2):413-414. PubMed ID: 34366030
[No Abstract] [Full Text] [Related]
12. A Moving Target: Integration of Smoking Cessation Into Screening for Second Primary Lung Cancer.
Aredo JV; Wakelee HA; Han SS
J Thorac Oncol; 2021 Aug; 16(8):e59-e60. PubMed ID: 34304856
[No Abstract] [Full Text] [Related]
13. Pairing smoking cessation with lung cancer screening may save lives.
Fillon M
CA Cancer J Clin; 2021 Jul; 71(4):283-284. PubMed ID: 34061366
[No Abstract] [Full Text] [Related]
14. [How to reduce lung cancer mortality among people living with HIV?].
Ruppert AM; Lavolé A; Makinson A; Le Maître B; Cadranel J
Rev Mal Respir; 2020 Mar; 37(3):267-274. PubMed ID: 32197931
[TBL] [Abstract][Full Text] [Related]
15. Tobacco and lung cancer.
Johnson BE
Prim Care; 1998 Jun; 25(2):279-91. PubMed ID: 9628951
[TBL] [Abstract][Full Text] [Related]
16. Better Together: Advancing Tobacco Use Treatment and Lung Cancer Screening.
Shoenbill KA; Goldstein AO
J Thorac Oncol; 2024 Apr; 19(4):531-533. PubMed ID: 38582544
[No Abstract] [Full Text] [Related]
17. Smoking cessation support lags behind lung cancer screenings.
Fillon M
CA Cancer J Clin; 2022 Sep; 72(5):405-406. PubMed ID: 36069379
[No Abstract] [Full Text] [Related]
18. Organizational Characteristics and Smoking Cessation Support in Community-Based Lung Cancer Screening Programs.
Bellinger C; Foley KL; Dressler EV; Kittel C; Miller DP; Weaver KE; Sutfin EL; Petty WJ; Spangler J; Stone R; Anderson DM; Kehn H; Steenstra C; Panikkar R; Chiles C;
J Am Coll Radiol; 2022 Apr; 19(4):529-533. PubMed ID: 35247325
[TBL] [Abstract][Full Text] [Related]
19. An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.
Graham AL; Burke MV; Jacobs MA; Cha S; Croghan IT; Schroeder DR; Moriarty JP; Borah BJ; Rasmussen DF; Brookover MJ; Suesse DB; Midthun DE; Hays JT
Trials; 2017 Nov; 18(1):568. PubMed ID: 29179734
[TBL] [Abstract][Full Text] [Related]
20. Predictors of attrition in a smoking cessation trial conducted in the lung cancer screening setting.
Kim E; Williams RM; Eyestone E; Cordon M; Smith L; Davis K; Luta G; Anderson ED; McKee B; Batlle J; Ramsaier M; Howell J; Parikh V; Geronimo M; Stanton C; Niaura R; Abrams D; Taylor KL;
Contemp Clin Trials; 2021 Jul; 106():106429. PubMed ID: 33964415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
